Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Neuromuscular blockade
ADR ID BADD_A03057
ADR Hierarchy
17      Nervous system disorders
17.05      Neuromuscular disorders
17.05.04      Neuromuscular junction dysfunction
17.05.04.003      Neuromuscular blockade
Description The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here. [MeSH]
MedDRA Code 10029315
MeSH ID D019148
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Block neuromuscular | Neuromuscular block | Neuromuscular blockade | Neuromuscular Blockade | Blockade, Neuromuscular | Neuromuscular Block | Block, Neuromuscular
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00104Amikacin sulfate--
BADD_D00188Atracurium besylate--
BADD_D00473Cisatracurium besylate--
BADD_D01076Homatropine hydrobromide--
BADD_D01552Neomycin sulfate--
BADD_D01864Propofol0.000179%
The 1th Page    1    Total 1 Pages